For the past 15 years I have practiced plant/algal synthetic biology with pioneers in the field such as Dr. Henry Daniell and in management positions at a number of startups. My specialty is in the design of new biologics for oral delivery to humans through engineering of plants (lettuce/tobacco) or algae (Chlamydomonas) for clinical or industrial applications. Through my contributions I strive to increase bioavailability and drive titers of our engineered proteins to high levels with an aim to translate our results in the lab to production level scale.
Chief Technology Officer
Leadership
Team Members
Olia Gaidarenko, PhD
Senior Scientist
Nathan Chang
Research Associate
Investors
Boom Capital
Investor
Climate Capital Bio
Investor
Jazz Venture Partners
Investor
Not Boring Capital
Investor
Nucleus Capital
Investor
Spacecadet Ventures
Investor
Plug and Play Ventures
Investor
BBQ Capital
Investor
Advisors
Justin Smith, PhD
Scientific/Business Advisor
Oliver Zill, PhD
Bioinformatics Advisor
Jennifer Brophy, PhD
Scientific Advisor, Plant Systems
Chris Hickey
Angel Investor/Advisor
Emily Culp
Angel Investor/Advisor
Kyle Schneider
Angel Investor/Advisor